【摘 要】
：
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive method of stimulating the brain that changes excitability at the site of stimulation as well as at distant anatomically connected
【机 构】
：
BDH-Klinik Greifswald Neurorehabilitation Centre and Spinal Cord Injury Unit Department of Neuroscie
论文部分内容阅读
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive method of stimulating the brain that changes excitability at the site of stimulation as well as at distant anatomically connected sites.The method has generated much interest as a potential therapeutic intervention in a wide range of neurological and psychiatric conditions including stroke sequelae.
其他文献
Learning healthy ways of living is central for the rehabilitation of patients with coronary artery disease.In order to develop a patient-centered education model, we used the idea of problem-based lea
Background: Despite dramatic decrease in coronary artery disease (CAD) of nearly 50% mortality reduction compared to 20 years ago, CAD is the leading cause of premature death in most European countrie
Western Medicine actively promotes pharmaceutical or surgical treatment of cardiovascular disease.Very little attention has been paid to prevention.It has become increasingly clear that lifestyle fact
Alzheimers disease (AD), a progressively neurodegenerative disorder termed as irreversible cognitive and physical deterioration, is considered as one of the most common forms of dementia.The etiology
Neuroimaging methods have gained significant momentum in Huntingtons disease (HD) research in recent years with high resolution techniques, like new developments in positron emission tomography (PET)
BACKGROUND AND PURPOSE: dowuregulation of the tumor suppressor, phosphatase and (tla)sin homolog deleted on chromosome 10 (PTEN), is thought to be a novel neuroprotective strategy in ischemic stroke,b
Atherosclerosis is a devastating chronic inflammatory disease, which results in intimal expansion of the large arteries, plaque formation, thrombosis and stroke or myocardial infarction.In advanced at
Symptomatic intracerebral hemorrhage (ICH) is the most dangerous adverse effect of tissue plasminogen activator (tPA), the only FDA-approved drug, for treating acute ischemic stroke patients.Currently
It is well known that gender differences exist in risk and outcome of ischemic stroke.In addition, surgical menopause (long term ovariectomy) is associated with an increased risk of Alzheimers disease
Stroke is caused by the sudden onset of loss of neurological functions because of the blood flow to the brain has been cut off which leads to cerebral ischemia.Axonal damage, neuronal loss and regener